Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study

Variability in Breast Cancer Biomarker Assessment and the Effect on Oncological Treatment Decisions: A Nationwide 5-Year Population-Based Study

We compared estrogen receptor (ER), progesterone receptor (PR), human epidermal growth-factor receptor 2 (HER2), Ki67, and grade scores among the pathology departments in Sweden. We investigated how ER and HER2 positivity rates affect the distribution of endocrine and HER2-targeted treatments among...

Full description

Bibliographic Details
Main Authors: Balazs Acs, Irma Fredriksson, Caroline Rönnlund, Catharina Hagerling, Anna Ehinger, Anikó Kovács, Rasmus Røge, Jonas Bergh, Johan Hartman
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Cancers
Subjects:
positivity rate
biomarker
breast cancer
endocrine treatment
HER2-targeted treatment
variability
Online Access:https://www.mdpi.com/2072-6694/13/5/1166

Internet

https://www.mdpi.com/2072-6694/13/5/1166

Similar Items